KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Total Non-Current Liabilities (2016 - 2023)

Historic Total Non-Current Liabilities for Biolife Solutions (BLFS) over the last 14 years, with Q4 2023 value amounting to $75.1 million.

  • Biolife Solutions' Total Non-Current Liabilities fell 1035.8% to $75.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $75.1 million, marking a year-over-year decrease of 1035.8%. This contributed to the annual value of $75.1 million for FY2023, which is 1035.8% down from last year.
  • As of Q4 2023, Biolife Solutions' Total Non-Current Liabilities stood at $75.1 million, which was down 1035.8% from $78.8 million recorded in Q3 2023.
  • Biolife Solutions' Total Non-Current Liabilities' 5-year high stood at $86.5 million during Q1 2023, with a 5-year trough of $5.0 million in Q2 2019.
  • Over the past 5 years, Biolife Solutions' median Total Non-Current Liabilities value was $63.2 million (recorded in 2021), while the average stood at $48.5 million.
  • Per our database at Business Quant, Biolife Solutions' Total Non-Current Liabilities surged by 71617.78% in 2021 and then crashed by 1035.8% in 2023.
  • Biolife Solutions' Total Non-Current Liabilities (Quarter) stood at $9.8 million in 2019, then skyrocketed by 156.84% to $25.1 million in 2020, then surged by 184.58% to $71.3 million in 2021, then grew by 17.36% to $83.7 million in 2022, then dropped by 10.36% to $75.1 million in 2023.
  • Its last three reported values are $75.1 million in Q4 2023, $78.8 million for Q3 2023, and $79.1 million during Q2 2023.